In 2018 NASS held two community engagement conferences called NASS Voices, in Scotland and Northern Ireland, aiming to bring together people with axial SpA (AS), their families and friends, local rheumatologists, nurses, physiotherapists and others interested in the condition. The team wanted people to come with questions and leave with answers.
Feedback indicated that these events truly delivered on their promise, so NASS is excited to be running four more events in 2019.
Cardiff: Saturday 13 April 2019
Southampton: Saturday 11 May 2019
Leeds: Saturday 7 September 2019
London: Saturday 16 November 2019
These events will feature practical talks and activities delivered by rheumatologists, physiotherapists, branch representatives and members of the NASS team.…
Read more of this article
FFN UK hip fracture review meeting at Wolfson College, Oxford on 8 May 2019.
In early February, ARMA was one of 55 signatories to an open letter published in The Times newspaper from the Association of Directors of Public Health. The letter argued that public health should be a priority in the Spending Review.
Versus Arthritis is excited to report that over 1,000 people have answered the survey on aids and adaptations.
Prevention seems to have been the theme of my February. The possibility that a lot of the pain and disability of MSK conditions might be prevented, and that this is being taken seriously is an exciting prospect. Even where the conditions can’t be prevented, good self-management support can make a big difference to the impact of the condition. The Government is clear that the future sustainability of the NHS depends on prevention, and that it wants to improve healthy life expectancy by at least five extra years, by 2035.… 
We all know that MSK is one of the two biggest causes of sickness absence in the UK. It’s perhaps no surprise that this is even more true in the construction sector. Every year, occupational ill‐health costs construction employers £848million in reduced productivity, sick pay, cover for absence and replacing staff who leave because of ill health. 
ARMA has welcomed the inclusion of references to MSK in the NHS Long Term Plan. The real challenge is how to implement this in the local NHS plans. ARMA has set out the “
FOREUM – Foundation for Research in Rheumatology – announces a programme to support innovative concepts to improve the diagnosis and treatment of Rheumatic Musculoskeletal Diseases (RMDs). This programme is designed as an open research call seeking for the best and most visionary approaches to better understand RMDs and to improve the life of patients with RMDs.
